{"name":"Apitope International NV","slug":"apitope-international-nv","ticker":"","exchange":"","domain":"","description":"Apitope International NV is a biotechnology company focused on the development of peptide-based therapies for autoimmune diseases and allergies. The company's lead candidate, ATX-GD-59, is currently in Phase 1 clinical trials. Apitope aims to address significant unmet medical needs through its innovative approach to modulating the immune system.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ATX-GD-59","genericName":"ATX-GD-59","slug":"atx-gd-59","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"ATX-GD-59","genericName":"ATX-GD-59","slug":"atx-gd-59","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxNWkhwVThMVHRmcjZzSHJwRWZxdW5ibWpSV1JHRV9IbktVY0E1Z3BHQUxaYlRVN013MjNaSjNvT0pUcThwa3d2TEFHbG1OaWNIaS0tU085aExDZnJMNE84ckR5eTdDVWlwVkEwaFMxVFZ4OFFvamU4ZnhkNUl2V0l0RGxjYU9GQ2JkRHQ4V2dhRHR1UUNDUVBxMmF6X0lNVVRMT2VVeUpuZXIzaEsxQWF6WWFwVWs4UmFYVHBPYU1ZOU0wbTdOZy1kMDZoMlpCYmJZYklJ?oc=5","date":"2026-03-20","type":"pipeline","source":"vocal.media","summary":"Peptide Therapeutics Market Outlook: Targeted Drug Development and Biopharmaceutical Innovation Opportunities - vocal.media","headline":"Peptide Therapeutics Market Outlook: Targeted Drug Development and Biopharmaceutical Innovation Opportunities","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxONjRKcDdKQmhDRm8tcTRtQ284UVRwZ0xHMDBLVktfc04wQnlDV1FVdERUM0ZOdHpZRkdDUDVrbDFtWHRaY3drUjh4LXJ5SmNiUWcxN29Vd1ZZcU1KemxZTFZCbHVmTzdCd3dRT3Fyd3kxanRZNFdaVTFSMm9Eclctai1fSjF1dHdBdUhjYU9VWQ?oc=5","date":"2026-02-24","type":"trial","source":"openPR.com","summary":"Graves' Disease Clinical Trials Outlook 2026: Market - openPR.com","headline":"Graves' Disease Clinical Trials Outlook 2026: Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxQRHJzUkc4ZFN3eHdhenFHVXdCLWdXVDJENi03d0F4TTZybTlSa3l2VzJ0Q29WcFBVMEZ1WjQyWUlXY0VnN0tRVk9GanBOSFVlZFVRZ0tkdjVKcGNOY1d3MmR2UFp1YU55UGNPU0tHWDBGbTM3YWNTTXY3ZU53cDlTZXJoWQ?oc=5","date":"2025-05-06","type":"pipeline","source":"businessweekly.co.uk","summary":"Qualified attorney is new Domainex CEO - businessweekly.co.uk","headline":"Qualified attorney is new Domainex CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingJBVV95cUxOZjRWa1pFTWZ4TjJuU3VTZ2VtMFNrVm9VTzJEamRhXzJwbmtjSHdKVmQ2NWtTbVlnYXZMWmRFbVZ2cXFDZEJVLWNFbDRqOTAzREZqcTZzWFdibkZBTlhyVHdKa3dvTXhhMHRNYnItUW9OWW5GUlBVYW1lUWNNRWl3ZW4zQWFURHkxOHU4S2ZMa1hRbG04TEE3ZlhrTzlTdXlSODhPcUtxalhXd1p3MUFBVEFZUEZHb3RzOEpaOENUelZZcWJuYVY5WkQ2WjNKcEhsdWRSbnZNQldpaEcyNmlGZFlRamN1U1dvWWtTVWJmOTYwa0VGaC1xOENzbWo1NlFuMmpsUGluZHRIYzdMcmxmby1SZHpGRGRMQTh1OVZB?oc=5","date":"2025-02-19","type":"pipeline","source":"globenewswire.com","summary":"TEPEZZA Market Sales on the Rise Due to the Strong Growth - globenewswire.com","headline":"TEPEZZA Market Sales on the Rise Due to the Strong Growth","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}